Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes (Q78044125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

D Tessier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P Maheux

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

T Fülöp

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

897-903

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

Gliclazide potentiates suppression of hepatic glucose production in non—insulin-dependent diabetic patients

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Sulfonylureas stimulate glucose uptake through GLUT4 transporter translocation in rat skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Oxidative damage, plasma antioxidant capacity, and glucemic control in elderly NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Nerve function and oxidative stress in diabetic and vitamin E-deficient rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Glibenclamide vs gliclazide in type 2 diabetes of the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Increased susceptibility of low-density lipoprotein (LDL) to oxidation by gamma-radiolysis with age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

A simple fluorometric assay for lipoperoxide in blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by gamma-radiolysis of ethanol-water mixtures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Pathogenesis of NIDDM. A balanced overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Release of superoxide radicals by mouse macrophages stimulated by oxidative modification of glycated low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Lipid peroxidation in type 2 normolipidemic diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Practical approaches to low density lipoprotein oxidation: whys, wherefores and pitfalls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Measuring free radical reactions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Total radical-trapping antioxidant parameter in NIDDM patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Partners in defense, vitamin E and vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

Antioxidant defense: vitamins E and C and carotenoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990226-3

10.1016/S0026-0495(99)90226-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421233%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference